Cetera Investment Advisers’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-36,700
Closed -$4.4K 4107
2024
Q4
$4.4K Sell
36,700
-221,301
-86% -$27.9K ﹤0.01% 3741
2024
Q3
$35.4K Hold
258,001
﹤0.01% 3621
2024
Q2
$37.7K Sell
258,001
-152
-0.1% -$23 ﹤0.01% 3614
2024
Q1
$37.7K Buy
258,153
+240,053
+1,326% +$33.6K ﹤0.01% 3592
2023
Q4
$3.62K Hold
18,100
﹤0.01% 2215
2023
Q3
$3.02K Hold
18,100
﹤0.01% 2181
2023
Q2
$3.62K Sell
18,100
-500
-3% -$101 ﹤0.01% 2173
2023
Q1
$3.94K Hold
18,600
﹤0.01% 2148
2022
Q4
$3.03K Buy
+18,600
New +$3.81K ﹤0.01% 2093
2021
Q1
Sell
-20,900
Closed -$5K 1747
2020
Q4
$5K Buy
+20,900
New +$2.67K ﹤0.01% 1556

Other funds holding ZOM

Cetera Investment Advisers's ZOM Position: Q1 2025 in Review

Cetera Investment Advisers sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 36,700 shares — an estimated $4.4K sold.

Cetera Investment Advisers first reported a position in ZOM in Q4 2020 and held it in 10 quarters. The position peaked at $37.7K in Q2 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Cetera Investment Advisers reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 36,700 Zomedica Corp. shares in Q1 2025, an estimated $4.4K.
  • Cetera Investment Advisers first reported a position in Zomedica Corp. in Q4 2020 and held it in 10 quarters.
  • Cetera Investment Advisers's Zomedica Corp. position peaked at $37.7K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Cetera Investment Advisers's 13F filing for Q1 2025, filed 6 May 2025.